Projekt 1 2024 - Lymphoma Challenge

Project

24–01

Status:

Running

Start:

21.09.2020–09.02.2023

Team L-R: Titel Vorname Name , Titel Vorname Name

Projekt 1 2024

Project

24–01

Projekt 1 2024

Status:

Running

Start:

21.09.2020–09.02.2023

Team L-R: Titel Vorname Name , Titel Vorname Name

Institutions  involved

Our expertise

Schreib einen Titel

Our expertise

Schreib einen Titel

Publications

link =

Project leader

Titel Name Vorname

ETH Zürich

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Titel Name Vorname

Clinic institution

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Project leader

Titel Name Vorname

ETH Zürich

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Titel Name Vorname

Clinic institution

Wirkungsorte und Icon-Link als Code am Ende des Textes $

You are currently at project

24–01

21–02

Understanding how clonal hematopoiesis feeds lymphoma

Prof. Dr. med. Andrea Alimonti

ETH Zurich

Prof. Dr. med. Emanuele Zucca

Ente Ospedaliero Cantonale (EOC) / Oncology Institute of Southern Switzerland (IOSI)

21–03

Overcoming the challenge of T-cell lymphoma treatment by safe and efficacious anti-CD30 radioimmunotherapy with β-particle and ultra-short range Auger and conversion electron emitting radionuclides

Prof. Dr. Roger Schibli

ETH Zurich

Prof. Dr. med. Urban Novak

Inselspital / University Hospital Bern

21–01

Effector-target cell interactions in engineered immune-therapy against hematologic malignancies

Prof. Dr. Timm Schroeder

ETH Zurich

Prof. Dr. med. Markus G. Manz

University Hospital Zurich

22–02

Regulatory T-cells as tumor-promoting cellular partners and potential therapeutic targets in diffuse large B-cell lymphoma

Prof. Dr. Nicola Aceto

ETH Zurich

Prof. Dr. Alexandar Tzankov

University Hospital Basel

22–01

Exploring the potential of targeting IL-21/IL-21R signaling to eliminate human acute myeloid leukemia stem cells

Prof. Dr. Manfred Kopf

ETH Zurich

Prof. Dr. Carsten Riether

Inselspital & University of Bern

23–01

Harnessing gut microbiome metabolism for personalized treatment of lymphoma and leukemia

Prof. Dr. Nicholas Bokulich

ETH Zurich

Prof. Dr. med. Jörg Halter

University Hospital Basel